Denali Therapeutics Inc (DNLI) Dividends

Dividend Overview

Dividend Yield

—

Dividend / Share

—

Key Metrics

Market Cap

$2.95B

P/E Ratio

-5.81

Forward P/E

—

EPS

$-2.97

PEG Ratio

0.50

Book Value

$6.39

Dividend Yield

—

Profit Margin

—

ROE

-50.11%

Dividend History

Dividend Safety

DNLI Dividend Analysis

Denali Therapeutics Inc (DNLI) dividend analysis including yield, payout history, and sustainability metrics.

P/E ratio: -5.81. Free cash flow: $-422.10M. This page shows Denali Therapeutics Inc's dividend overview, key metrics, historical payout data, and dividend safety assessment to help income-focused investors evaluate the sustainability of dividend payments.

GoodMoat's dividend analyzer evaluates payout ratios, earnings coverage, and free cash flow coverage to determine how well supported Denali Therapeutics Inc's dividend payments are. Use this analysis alongside the company's financial statements and quality score to make informed income-investing decisions.